Business Context and Reporting Period
Company: ASTROTECH Corp (Nasdaq: ASTC)
Filing Type: Form 10-K (Annual Report)
Period Ended: June 30, 2011
Astrotech is a commercial aerospace company providing spacecraft payload processing services through its Astrotech Space Operations (ASO) unit and incubating space technology businesses through its Spacetech unit. ASO accounted for 98% of consolidated revenues in fiscal 2011. The company operates facilities in Titusville, Florida, and Vandenberg Air Force Base, California.
Key Financial Metrics
| Metric | Fiscal 2011 | Fiscal 2010 |
|---|---|---|
| Revenue | $20.1 million | $28.0 million |
| Gross Profit | $6.5 million | $15.1 million |
| Gross Margin | 32% | 54% |
| Net Loss | $(6.0) million | $(0.3) million |
| Net Loss Attributable to Astrotech | $(5.0) million | $0.3 million (Income) |
| EPS (Basic) | $(0.28) | $0.02 |
| Cash and Cash Equivalents | $15.0 million | $8.1 million |
| Working Capital | $5.0 million | $2.6 million |
| Total Debt (Current + Long-term) | $6.8 million | $8.5 million |
| Operating Cash Flow | $9.2 million | $4.4 million |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 28% to $20.1 million, primarily due to a decreased launch schedule and the absence of one-time construction revenue recognized in 2010 for the new five-meter facility at Vandenberg Air Force Base.
- Profitability Shift: The company moved from a net income of $0.3 million in 2010 to a net loss of $6.0 million in 2011. Gross margin contracted significantly from 54% to 32% due to lower revenue volumes against fixed operating costs.
- Expense Trends: Selling, general, and administrative (SG&A) expenses decreased by $3.8 million due to headcount reductions and lower consulting fees. Conversely, Research and Development (R&D) expenses increased by $1.0 million to $3.8 million, driven by investments in the 1st Detect Miniature Chemical Detector.
- Liquidity Improvement: Cash and cash equivalents increased by $6.9 million to $15.0 million, driven by strong operating cash flows and a $9.0 million increase in deferred revenue related to a Ground Support Equipment (GSE) contract.
- Debt Restructuring: In October 2010, the company retired $5.1 million in Senior Convertible Notes and a $3.4 million legacy term note, replacing them with a new $7.0 million term loan and a $3.0 million revolving credit facility.
Guidance, Outlook, Risks, and Unusual Items
- Backlog: The 18-month rolling backlog stood at $35.2 million as of June 30, 2011, consisting primarily of ASO pre-launch services and Spacetech grants.
- Spacetech Development: The Spacetech unit remains in an early development stage with limited revenue ($0.3 million). Key initiatives include 1st Detect (chemical detection) and Astrogenetix (vaccine development). The unit incurred a net loss of $6.4 million.
- Regulatory Risks: On August 30, 2011 (post-period), the company received a NASDAQ Staff Determination letter indicating failure to maintain the $1.00 minimum bid price, subjecting the stock to potential delisting.
- Customer Concentration: Approximately 73% of revenue in 2011 was derived from NASA and U.S. Government contracts, creating significant dependency risk.
- Subsequent Events: In September 2011, ASO was awarded a $4.0 million contract for payload processing services, and 1st Detect received the second tranche of its Texas Emerging Technology Fund award ($0.9 million).
Investor Verification Checklist
- Delisting Status: Verify current compliance with NASDAQ bid price requirements and the status of any delisting proceedings initiated in August 2011.
- Deferred Revenue Recognition: Confirm the timeline for recognizing the $9.0 million increase in deferred revenue from the GSE contract to assess future revenue visibility.
- Government Contract Renewals: Assess the renewal status of key NASA and U.S. Government contracts, which comprised 73% of revenue.
- Spacetech Funding: Evaluate the capital requirements for the Spacetech unit, which is currently unprofitable and reliant on grants and equity financing.
- Debt Covenants: Review the terms of the new $7.0 million term loan to ensure ongoing compliance with financial covenants.